&Partners’s Medline Inc MDLN Stock Holding History

&Partners’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$350K	Buy	8,864 +2,175	+33%	+$87.6K	﹤0.01%	2043
2026 Q1	$298K	Buy	+6,689	New	+$295K	﹤0.01%	1998

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

&Partners's MDLN Position: Q2 2026 in Review

&Partners increased its Medline Inc (MDLN) stake by 33% in Q2 2026, buying an estimated $87.6K and bringing the position to 8,864 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #2043.

&Partners first reported a position in MDLN in Q1 2026 and has held it in 2 quarters since. 407 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

&Partners held 8,864 shares of Medline Inc worth $350K as of Q2 2026.
&Partners bought 2,175 Medline Inc shares in Q2 2026, an estimated $87.6K.
Medline Inc made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #2043 holding.
&Partners first reported a position in Medline Inc in Q1 2026 and has held it in 2 quarters since.
407 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.